Acorda Therapeutics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Acorda Therapeutics, Inc. had Stockholders' Equity Attributable to Noncontrolling Interest of $9.90 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2016-08-04
- 2016-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $9.90M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2016-06-30 | $9.90M 10-Q · filed 2016-08-04 |